World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
71
Citations
23474
World Ranking
2282
National Ranking
1107

Overview

Qizhi Tang is affiliated with the University of California, San Francisco in the United States. Their research primarily centers on medicine with a strong emphasis on immunology and microbiology.

The scientist has contributed extensively to subfields such as immunology, oncology, genetics, surgery, and endocrinology, diabetes, and metabolism. Their main topics of work include:

  • T-cell and B-cell Immunology
  • Immune Cell Function and Interaction
  • CAR-T cell therapy research
  • Diabetes and associated disorders
  • Renal Transplantation Outcomes and Treatments
  • Pancreatic function and diabetes
  • Diabetes Management and Research

Tang's work has appeared frequently in several publication venues, notably:

  • Frontiers in Immunology
  • bioRxiv (Cold Spring Harbor Laboratory)
  • American Journal of Transplantation
  • The Journal of Immunology
  • Science Translational Medicine

Selected recent papers authored or coauthored by Qizhi Tang include:

  • Regulatory cell therapy in kidney transplantation (The ONE Study): a harmonised design and analysis of seven non-randomised, single-arm, phase 1/2A trials, 2020, The Lancet
  • The effect of low-dose IL-2 and Treg adoptive cell therapy in patients with type 1 diabetes, 2021, JCI Insight
  • The CD28-Transmembrane Domain Mediates Chimeric Antigen Receptor Heterodimerization With CD28, 2021, Frontiers in Immunology
  • Functional CRISPR dissection of gene networks controlling human regulatory T cell identity, 2020, Nature Immunology
  • Precision Engineering of an Anti-HLA-A2 Chimeric Antigen Receptor in Regulatory T Cells for Transplant Immune Tolerance, 2021, Frontiers in Immunology

Frequent coauthors working alongside Tang include:

  • Jeffrey A. Bluestone
  • Vinh Nguyen
  • Yannick D. Müller
  • Patrick Ho
  • Leonardo M. R. Ferreira

Best Publications

  • In Vitro–expanded Antigen-specific Regulatory T Cells Suppress Autoimmune Diabetes

    Qizhi Tang;Kammi J. Henriksen;Mingying Bi;Erik B. Finger

  • The Foxp3+ regulatory T cell: a jack of all trades, master of regulation.

    Qizhi Tang;Jeffrey A Bluestone

  • Type 1 diabetes immunotherapy using polyclonal regulatory T cells.

    Jeffrey A. Bluestone;Jane H. Buckner;Mark Fitch;Stephen E. Gitelman

  • Visualizing regulatory T cell control of autoimmune responses in nonobese diabetic mice

    Qizhi Tang;Jason Yeates Adams;Aaron J. Tooley;Mingying Bi

  • IRE1α Induces Thioredoxin-Interacting Protein to Activate the NLRP3 Inflammasome and Promote Programmed Cell Death under Irremediable ER Stress

    Alana G. Lerner;John Paul Upton;P. V.K. Praveen;Rajarshi Ghosh

  • Interactions between PD-1 and PD-L1 promote tolerance by blocking the TCR-induced stop signal.

    Brian T Fife;Kristen E Pauken;Todd N Eagar;Takashi Obu

  • Cutting edge: CD28 controls peripheral homeostasis of CD4+CD25+ regulatory T cells.

    Qizhi Tang;Kammi J. Henriksen;Elisa K. Boden;Aaron J. Tooley

  • Central role of defective interleukin-2 production in the triggering of islet autoimmune destruction.

    Qizhi Tang;Jason Yeates Adams;Cristina Penaranda;Kristin Melli

  • Loss of integrin αvβ8 on dendritic cells causes autoimmunity and colitis in mice

    Mark A. Travis;Boris Reizis;Andrew C. Melton;Emma Masteller

  • Distinct roles of CTLA-4 and TGF-β in CD4+CD25+ regulatory T cell function

    Qizhi Tang;Elisa K. Boden;Kammi J. Henriksen;Helene Bour‐Jordan

  • IL-2 reverses established type 1 diabetes in NOD mice by a local effect on pancreatic regulatory T cells

    Yenkel Grinberg-Bleyer;Audrey Baeyens;Sylvaine You;Rima Elhage

  • Next-generation regulatory T cell therapy.

    Leonardo M. R. Ferreira;Yannick D. Muller;Jeffrey A. Bluestone;Qizhi Tang

  • Herpes simplex virus glycoproteins E and I facilitate cell-to-cell spread in vivo and across junctions of cultured cells

    Kevin S. Dingwell;Craig R. Brunetti;Robert L. Hendricks;Qizhi Tang

  • Insulin-induced remission in new-onset NOD mice is maintained by the PD-1–PD-L1 pathway

    Brian T. Fife;Indira Guleria;Melanie Gubbels Bupp;Melanie Gubbels Bupp;Todd N. Eagar

  • Regulatory cell therapy in kidney transplantation (The ONE Study): a harmonised design and analysis of seven non-randomised, single-arm, phase 1/2A trials.

    Birgit Sawitzki;Paul N Harden;Petra Reinke;Aurélie Moreau

  • How do CD4+CD25+ regulatory T cells control autoimmunity?

    Jeffrey A Bluestone;Qizhi Tang

  • Regulatory T-cell physiology and application to treat autoimmunity

    Qizhi Tang;Jeffrey A. Bluestone

  • Inflammatory infiltration of the trigeminal ganglion after herpes simplex virus type 1 corneal infection

    Ting Liu;Q. Tang;R. L. Hendricks

  • ERM-dependent movement of CD43 defines a novel protein complex distal to the immunological synapse.

    Eric J. Allenspach;Patrick Cullinan;Jiankun Tong;Qizhi Tang

  • Expansion of Functional Endogenous Antigen-Specific CD4+CD25+ Regulatory T Cells from Nonobese Diabetic Mice

    Emma L. Masteller;Matthew R. Warner;Qizhi Tang;Kristin V. Tarbell

  • IRE1α Induces Thioredoxin-Interacting Protein to Activate the NLRP3 Inflammasome and Promote Programmed Cell Death under Irremediable ER Stress

    Alana G. Lerner;John-Paul Upton;P.V.K. Praveen;Rajarshi Ghosh

Frequent Co-Authors

Jeffrey A. Bluestone
Jeffrey A. Bluestone University of California, San Francisco
Tejal A. Desai
Tejal A. Desai University of California, San Francisco
Flavio Vincenti
Flavio Vincenti University of California, San Francisco
Robert L. Hendricks
Robert L. Hendricks University of Pittsburgh
Matthew F. Krummel
Matthew F. Krummel University of California, San Francisco
Edward K. Geissler
Edward K. Geissler University of Regensburg
Matthias Hebrok
Matthias Hebrok University of California, San Francisco
Alexander Marson
Alexander Marson University of California, San Francisco
Giovanna Lombardi
Giovanna Lombardi King's College London
Hideo Yagita
Hideo Yagita Juntendo University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in advancing their immunology knowledge with clinical expertise, exploring related online degrees is a smart move. Programs like the best pmhnp programs online offer specialized training in psychiatric mental health nurse practitioner roles, which often complement immunological studies through a focus on the immune system’s impact on mental health.

Cost is an important consideration. Students seeking budget-friendly options can find the cheapest psych np programs, balancing quality education with affordability. These programs provide pathways for students to enhance their credentials while managing educational expenses.

When choosing a career path, understanding potential earnings is key. The highest paid dnp specialties highlight lucrative opportunities within nursing disciplines that overlap with immunology, especially in advanced practice roles.

If you already have a Family Nurse Practitioner (FNP) certification, transitioning to more specialized care can be seamless. Guidance on how to fnp to acute care certification can open doors to acute and critical care settings where immunology expertise is highly valued.

Best Scientists Citing Qizhi Tang

Trending Scientists

Recently Published Articles